TY - JOUR
T1 - A map of enhancer regions in primary human neural progenitor cells using capture STARR-seq
AU - PsychENCODE Consortium
AU - Gaynor-Gillett, Sophia C.
AU - Cheng, Lijun
AU - Shi, Manman
AU - Liu, Jason
AU - Wang, Gaoyuan
AU - Spector, Megan
AU - Guo, Qiuyu
AU - Qi, Le
AU - Flaherty, Mary
AU - Wall, Martha
AU - Hwang, Ahyeon
AU - Gu, Mengting
AU - Chen, Zhanlin
AU - Chen, Yuhang
AU - Moran, Jennifer R.
AU - Zhang, Jing
AU - Lee, Donghoon
AU - Gerstein, Mark
AU - Geschwind, Daniel H.
AU - White, Kevin P.
AU - Akbarian, Schahram
AU - Abyzov, Alexej
AU - Ahituv, Nadav
AU - Arasappan, Dhivya
AU - Armenteros, Jose Juan Almagro
AU - Beliveau, Brian J.
AU - Bendl, Jaroslav
AU - Berretta, Sabina
AU - Bharadwaj, Rahul A.
AU - Bhattacharya, Arjun
AU - Bicks, Lucy
AU - Brennand, Kristen
AU - Capauto, Davide
AU - Champagne, Frances A.
AU - Chatterjee, Tanima
AU - Chatzinakos, Chris
AU - Isaac Chen, H.
AU - Cheng, Yuyan
AU - Cheng, Lijun
AU - Chess, Andrew
AU - Chien, Jo Fan
AU - Chu, Zhiyuan
AU - Clarke, Declan
AU - Clement, Ashley
AU - Collado-Torres, Leonardo
AU - Cooper, Gregory M.
AU - Crawford, Gregory E.
AU - Dai, Rujia
AU - Daskalakis, Nikolaos P.
AU - Liu, Chunyu
AU - Davila-Velderrain, Jose
N1 - Publisher Copyright: © 2025 Gaynor-Gillett et al.
PY - 2025/8
Y1 - 2025/8
N2 - Genome-wide association studies (GWASs) and expression analyses implicate noncoding regulatory regions as harboring risk factors for psychiatric disease, but functional characterization of these regions remains limited. Here, we perform capture STARR-sequencing of over 70,000 candidate regions to identify active enhancers in primary human neural progenitor cells (phNPCs). We select candidate regions by integrating data from NPCs, prefrontal cortex, developmental timepoints, and GWASs. Over 8000 regions demonstrate enhancer activity in the phNPCs, and we link these regions to over 2200 predicted target genes. These genes are involved in neuronal and psychiatric disease-associated pathways, including neuronal system, nervous system development, and developmental delay. We functionally validate a subset of these enhancers using mutation STARR-sequencing and CRISPR deletions, demonstrating the effects of genetic variation on enhancer activity and enhancer deletion on gene expression. Overall, we identify thousands of highly active enhancers and functionally validated a subset of these enhancers, improving our understanding of regulatory networks underlying brain function and disease.
AB - Genome-wide association studies (GWASs) and expression analyses implicate noncoding regulatory regions as harboring risk factors for psychiatric disease, but functional characterization of these regions remains limited. Here, we perform capture STARR-sequencing of over 70,000 candidate regions to identify active enhancers in primary human neural progenitor cells (phNPCs). We select candidate regions by integrating data from NPCs, prefrontal cortex, developmental timepoints, and GWASs. Over 8000 regions demonstrate enhancer activity in the phNPCs, and we link these regions to over 2200 predicted target genes. These genes are involved in neuronal and psychiatric disease-associated pathways, including neuronal system, nervous system development, and developmental delay. We functionally validate a subset of these enhancers using mutation STARR-sequencing and CRISPR deletions, demonstrating the effects of genetic variation on enhancer activity and enhancer deletion on gene expression. Overall, we identify thousands of highly active enhancers and functionally validated a subset of these enhancers, improving our understanding of regulatory networks underlying brain function and disease.
UR - https://www.scopus.com/pages/publications/105012941966
U2 - 10.1101/gr.279584.124
DO - 10.1101/gr.279584.124
M3 - Article
C2 - 40645663
SN - 1088-9051
VL - 35
SP - 1887
EP - 1901
JO - Genome Research
JF - Genome Research
IS - 8
ER -